Objectives: Trial registration has a great potential to increase research transparency and public access to research results. This study examined the availability of results either in journal publications or in the trial registry from all studies registered at ClinicalTrials.gov. Methods: All 137,612 records from ClinicalTrials.gov in December 2012 were merged with all 19,158 PubMed records containing registration numbers in the indexing field or in the abstracts. A multivariate analysis was conducted to examine the association between the availability of the results with study and participant characteristics available in registration records. Results: Fewer than 10% of the registered studies and 15% of the registered and completed studies had published results. The highest publication rate of 22.4% was for randomized trials completed between 2005 (starting year for structured indexing in PubMed of study registration) and 2010. For 86% of overall and 78% of completed registered studies, no results were available in ClinicalTrials.gov or in journal publications. Studies funded by industry vs. other funding sources and drug studies vs. all studies of other interventions were published less often after adjustment for study type, subject characteristics, or posting of results in ClinicalTrials.gov. Conclusion: Existing policy does not ensure availability of results from clinical research. International policy revisions should charge principal investigators with ensuring that the approved protocols and posted data elements are aligned and that results are available from all conducted studies.
|Original language||English (US)|
|Number of pages||12|
|Journal||Journal of Epidemiology and Global Health|
|State||Published - Mar 2014|
Bibliographical noteFunding Information:
International AllTrials campaign (available at http://www.alltrials.net ) calls for registration and results reporting for all clinical studies. Sharing clinical research data is supported by the World Health Organization (WHO), the US National Institutes of Health (NIH), the Cochrane collaboration, the Institute of Medicine and other respected international organizations  . All clinical studies should be registered before recruitment of the first participant [18,35] in trial registries that comply with the World Health Organization (WHO) minimum dataset  . Trial registration should be mandatory irrespective of trial phase or design, study completion, foreign participant residency, market status of the examined interventions, or voluntary publication status [18,35,37,38] .
- Clinical epidemiology
- Clinical research Standards
- Evidence based medicine
- Publication bias